Free tool
FAERS Monitor: Prevymis
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 209940 or its brand name (Prevymis, Letermovir). Reports on generic versions are filed under their own applications.
Reports
3,257
Serious
2,664
82% of reports
Hospitalization
1,280
Death reported
588
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use718
- drug ineffective295
- cytomegalovirus infection reactivation260
- death196
- acute kidney injury178
- cytomegalovirus infection173
- drug interaction166
- product use in unapproved indication165
- pancytopenia153
- drug resistance99
- hospitalisation99
- pyrexia99
- product dose omission issue98
- cytomegalovirus viraemia96
- diarrhoea93
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2017 | 1 |
| 2018 | 82 |
| 2019 | 257 |
| 2020 | 272 |
| 2021 | 395 |
| 2022 | 379 |
| 2023 | 413 |
| 2024 | 503 |
| 2025 | 557 |
| 2026 | 398 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,902 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| cytomegalovirus infection reactivationSignal | 260 | 403.8 | 357.9 | 97,958 |
| cytomegalovirus viraemiaSignal | 96 | 142.4 | 116.7 | 13,054 |
| cytomegalovirus infectionSignal | 173 | 67.9 | 58.7 | 11,230 |
| drug resistanceSignal | 99 | 25.0 | 20.6 | 2,249 |
| pancytopeniaSignal | 153 | 17.7 | 15.2 | 2,398 |
| acute kidney injurySignal | 178 | 7.5 | 6.5 | 1,006 |
| drug interactionSignal | 166 | 6.8 | 5.8 | 815 |
| off label useSignal | 718 | 5.3 | 5.0 | 2,606 |
| product use in unapproved indicationSignal | 165 | 4.3 | 3.7 | 419 |
| hospitalisationSignal | 99 | 4.2 | 3.4 | 236 |
| product dose omission issueSignal | 98 | 2.2 | 1.8 | 60 |
| pyrexia | 99 | 1.8 | 1.5 | 38 |
| death | 196 | 1.5 | 1.3 | 30 |
| drug ineffective | 295 | 1.4 | 1.3 | 43 |
| diarrhoea | 93 | 0.9 | 0.8 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.